Event Calendar
Prev MonthPrev Month Next MonthNext Month
Signature Series | Women on Boards
4655 Executive Drive
San Diego, CA 92121
Tuesday, June 11, 2019, 5:30 PM - 8:00 PM PST
Category: Signature Series

Contact Jessica Simington to be added to the wait list

Signature Series
Women Leading from the Boardroom

California has become the first state to require any publicly held corporation headquartered in California to have a representative number of women on its board of directors. California Senate Bill 826 requires one female on the board of directors by the end of 2019 and companies with six or more members will be required to have at least three women by the end of 2021.

Meet Our Panel

Annalisa Barrett (Moderator)
Senior Advisor | KPMG Board Leadership Center
Annalisa Barrett is a Senior Advisor with the KPMG Board Leadership Center, where she plays a key role in the development of research and thought leadership and advises directors on emerging trends in corporate governance. She has been quoted in the New York Times, Bloomberg, and the Financial Times, and her research has been featured in the Wall Street Journal.
Prior to joining KPMG, Barrett was CEO of Board Governance Research LLC. Barrett was also a Senior Advisor for ValueEdge Advisors, and Vice President and Senior Research Associate at The Corporate Library (now MSCI ESG Research). She previously was a Research Consultant in the Executive Compensation practice at Towers Perrin (now Willis Towers Watson) and a Tax Consultant in the Family Wealth Planning practice of Arthur Andersen.
Barrett is an adjunct lecturer at the University of San Diego School of Business. In 2018, she was appointed to the Insurance Diversity Task Force, which works to increase the board diversity of insurance companies that do business in California.
For over a decade, Barrett has served on the board of the Corporate Directors Forum. In 2008, she was named a Millstein Rising Star in Corporate Governance by the Millstein Center for Global Markets and Corporate Ownership at Columbia Law School. She is a Fellow of the US-Japan Leadership Program, a member of the International Corporate Governance Network, the Society for Corporate Governance, and the 30% Coalition. She serves as the San Diego Campaign Co-Chair for 2020 Women on Boards. She holds an MBA, with distinction, from the Ross School of Business at the University of Michigan.

Carol Gallagher, Pharm.D.
Partner | New Enterprise Associates
Carol Gallagher joined NEA in October, 2014. She is primarily focused on making biopharma investments. Carol is a proven entrepreneur, operator and more recently investor with nearly 30 years of experience in commercial, drug development and business development roles. Prior to joining NEA she was a Venture Partner with Frazier Healthcare and she served as an independent director on multiple Boards. From 2008-2011, Carol was president and CEO of Calistoga Pharmaceuticals which developed the first-in-class therapeutic now marketed by Gilead as ZYDELIG.
She currently serves as Chairman of the Board at Millendo Therapeutics, lead director at Atara Bio, and as a director at Metacrine, PIONYR Immunotherapeutics, Cleave Biosciences, AnaptysBio, and Xoc Pharmaceuticals.

Laura Siegal
Chief Financial Officer | Natel Engineering, Inc.
Laura is responsible for all aspects of the Company’s financial strategies, operations and processes. She has over twenty years of experience in the defense and technology industries with broad experience in corporate financial planning and analysis, mergers and acquisitions, accounting, treasury and tax. Laura joined NEO Tech in July 2013 from Kratos Defense & Security Solutions, Inc., where she served as Vice President and Corporate Controller and Vice President of Finance and Treasurer. Prior to Kratos, she served in various positions at MEC Analytical Systems and GEC-Marconi. She is a Certified Public Accountant in the State of California and holds a Bachelor’s degree in Economics from the University of California, San Diego. 

Robin Toft
Founder, CEO | Toft Group Executive Search
Robin Toft is the founder and CEO of Toft Group Executive Search, where she combines a deep inside knowledge of the life science industry with a passion for building game-changing management teams. In over a decade in the executive search industry, Robin has placed members of boards of directors, CEOs, COOs, CFOs, CCOs, CMOs, CTOs and other senior management positions in North American companies in biotechnology, pharmaceuticals, diagnostics, medical devices, life science tools and digital health. A champion of diverse executive teams, Robin has built a reputation for recruiting women and minorities into top roles and helping the life science industry overcome unconscious bias in hiring. 
Robin is the author of the book “WE CAN, the Executive Woman’s Guide to Career Advancement” (available through www.RobinToft.com), and leads Toft Group’s WE CAN™ movement to expand networking and learning opportunities for female executives nationwide.
In 2006 Robin launched a second career in executive search, following more than two decades as a biotech executive. Her prior roles include senior Vice President of Global Commercial Operations at Roche, Vice President of Virology at Roche, and Executive Vice President of Marketing and Sales at ViroLogic Inc. (now Monogram Biosciences), a San Francisco startup where she was instrumental in the company’s first product launches and IPO. Robin also served in a variety of senior management posts at LabCorp, one of the world’s largest clinical diagnostic companies, after beginning her career at SmithKline Beecham Clinical Laboratories.
Robin serves on the board of Scripps Mercy Hospital FoundationThe Clearity Foundation, supporting ovarian cancer patients, and LEAD San Diego, the only organization in greater San Diego dedicated to developing civically engaged leaders. Additionally, Robin has been active on American Heart Association’s “Go Red for Women” executive leadership team and has participated in the annual Susan G. Komen 3-day walk to support breast cancer research since 2010. Robin’s leadership talents have not gone unnoticed: she was awarded Woman of the Year in 2017 by the San Diego Business Journal, in 2018 she was a finalist in Ernst & Young’s prestigious Entrepreneur of the Year awards, and she’s been honored as a finalist for San Diego Business Journal’s “Women Who Mean Business” and “Most Admired CEO” awards in multiple years. 
Robin holds a B.S. in Medical Technology (Clinical Laboratory Science) from Michigan State University and a teaching credential from San Diego State University.

Date/Time      June 11, 2019 | 5:30 - 8:30 PM
5:30 - 6:15 pm | registration and networking
6:15 - 6:30 pm | welcomes and introductions
6:30 - 8:00 pm | program
8:00 pm | program wrap
Location KPMG | 4655 Executive Drive, San Diego
Cost $35 Members; $55 Non-Members
Sponsored members complimentary with code

Empowered by